Targeted Therapeutic Approaches in Cancer: Combining Natural Compounds and Conventional Drugs
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 11
Special Issue Editor
Interests: cancer chemotherapy; pharmacology; signal transduction; invasion; combination therapy; apoptosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
There is mounting evidence in the literature that bioactive natural compounds affect the progression of cancers, relating to molecular mechanisms as well as epidemiological studies. Natural compounds exhibit anti-proliferative, anti-invasive, proapoptotic, antiangiogenic, metabolic and antimetastatic activities. Bioactive natural compounds have also been known to affect the immune system. Since these bioactive natural compounds are sometimes included in diet, it is imperative that they have synergistic effects in patients undergoing therapeutic treatment. Investigations into these compounds will also help in recommending that patients avoid or add these natural products during therapy. Understanding these mechanisms and their implications for cancer is critical not only for the treatment but also the prevention of cancers. This Special Issue focuses on molecular, genetic, immunologic, metabolic and epidemiological investigations.
Prof. Dr. Alok Bhushan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural compounds
- cancer
- repurposing
- combination
- polychemotherapy
- pharmaceuticals
- nutraceuticals
- molecular targets
- metabolomics
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
